Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé

Dafna D Gladman; Philip J Mease; Paul Bird; Enrique R Soriano; Soumya D Chakravarty; May Shawi; Frederic Lavie; Cinty Gong; Evan Leibowitz; Denis Poddubnyy; Lai-Shan Tam; Philip S Helliwell; Arthur Kavanaugh; Atul A Deodhar; Mikkel Østergaard; Xenofon Baraliakos

doi:10.1136/annrheumdis-2022-222161

Back

Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé

Journal article

Open access

Peer reviewed

Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé

Dafna D Gladman, Philip J Mease, Paul Bird, Enrique R Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, …

Annals of the rheumatic diseases, pannrheumdis-2022-222161

29 Apr 2022

DOI: https://doi.org/10.1136/annrheumdis-2022-222161

PMID: 35487679

Featured in Collection : UN Sustainable Development Goals @ Drexel

Files and links (1)

url

https://doi.org/10.1136/annrheumdis-2022-222161View

Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze), Open

Abstract

arthritis, psoriatic

Correspondence

cytokines

spondylitis, ankylosing

Metrics

10 Record Views

7 citations in Web of Science

5 citations in Scopus

Details

Title: Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé
Creators: Dafna D Gladman - Toronto Western Hospital
Philip J Mease - Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA
Paul Bird - UNSW Sydney
Enrique R Soriano - Hospital Italiano de Buenos Aires
Soumya D Chakravarty - Product Innovation and Engineering (United States) (United States, Saint James) - LLC
May Shawi - Johnson & Johnson
Frederic Lavie - Johnson & Johnson
Cinty Gong - Immunology, Janssen Scientific Affairs LLC, Horsham, Pennsylvania, USA
Evan Leibowitz - Immunology, Janssen Scientific Affairs LLC, Horsham, Pennsylvania, USA
Denis Poddubnyy - Charité - University Medicine Berlin
Lai-Shan Tam - Chinese University of Hong Kong
Philip S Helliwell - University of Leeds
Arthur Kavanaugh - University of California, San Diego
Atul A Deodhar - Oregon Health & Science University
Mikkel Østergaard - University of Copenhagen
Xenofon Baraliakos - Rheumazentrum Ruhrgebiet
Publication Details: Annals of the rheumatic diseases, pannrheumdis-2022-222161
Publisher: BMJ Publishing Group Ltd and European League Against Rheumatism
Grant note: NA / Janssen Scientific Affairs (http://dx.doi.org/10.13039/100017183)
Resource Type: Journal article
Language: English
Academic Unit: Rheumatology
Web of Science ID: WOS:000789915100001
Scopus ID: 2-s2.0-85130850111
Other Identifier: 991019167425304721

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Rheumatology

Correspondence on ‘No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related ‘physician-reported spondylitis’?’ by Braun and Landewé

Files and links (1)

Abstract

Metrics

Details

UN Sustainable Development Goals (SDGs)

InCites Highlights

Drexel University Social media